Evidence for the
Candidate genes
DRD2 gene
GWAS
Hypodopaminergia
Polymorphisms
Reward deficiency and addictive and non- addictive behaviors
Journal
Clinical and experimental psychology
ISSN: 2471-2701
Titre abrégé: Clin Exp Psychol
Pays: United States
ID NLM: 101712258
Informations de publication
Date de publication:
29 Jun 2023
29 Jun 2023
Historique:
medline:
10
8
2023
pubmed:
10
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
Since 1990, published addiction psychiatry articles have exceeded 11,495. Several from Blum et al. showed the clinical relevance of the Genetic Addiction Risk Severity (GARS) test in identifying risk for reward deficiency behaviors in cohorts from polysubstance and pain clinics, post-surgical bariatrics, and DWI offenders facing prison time. Since Blum
Types de publication
Journal Article
Langues
eng
Pagination
8-11Subventions
Organisme : NIDA NIH HHS
ID : R21 DA045640
Pays : United States
Organisme : CSRD VA
ID : I01 CX002099
Pays : United States
Organisme : NIDA NIH HHS
ID : R33 DA045640
Pays : United States
Organisme : NIMHD NIH HHS
ID : R41 MD012318
Pays : United States
Organisme : CSRD VA
ID : I01 CX000479
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest Dr. Kenneth Blum is the inventor of both GARS and KB220 which has been assigned to Transplicegen Holdings, Inc. There are no other conflicts of interest.
Références
JAMA. 1990 Dec 26;264(24):3156-60
pubmed: 1979357
Nat Neurosci. 2021 Jul;24(7):954-963
pubmed: 34045744
J Pers Med. 2022 Aug 26;12(9):
pubmed: 36143170
Drug Alcohol Depend. 1993 Oct;33(3):271-85
pubmed: 8261891
JAMA. 1990 Apr 18;263(15):2094-5
pubmed: 2157075
World J Biol Psychiatry. 2012 Jan;13(1):65-74
pubmed: 21247255
JAMA Netw Open. 2019 Nov 1;2(11):e1914940
pubmed: 31702801
Am J Psychiatry. 1990 Jun;147(6):719-24
pubmed: 2343913
Biochem Med Metab Biol. 1993 Oct;50(2):176-85
pubmed: 8260195
Med Hypotheses. 2005;65(4):703-7
pubmed: 15964153
Addict Biol. 2021 Jan;26(1):e12880
pubmed: 32064741
JAMA. 1991 Oct 2;266(13):1793-800
pubmed: 1832466
Alcohol Clin Exp Res. 2008 Dec;32(12):2117-27
pubmed: 18828801
J Behav Addict. 2020 Jun 26;9(2):272-288
pubmed: 32609628
Neurosci Biobehav Rev. 1985 Fall;9(3):469-77
pubmed: 2999657
Mol Psychiatry. 2022 Apr;27(4):2264-2272
pubmed: 35347246
Life Sci. 2005 May 27;77(2):130-9
pubmed: 15862598
J R Soc Med. 1996 Jul;89(7):396-400
pubmed: 8774539
Hum Mutat. 2004 Jun;23(6):540-5
pubmed: 15146457
Am J Hum Genet. 1989 Nov;45(5):778-85
pubmed: 2573278
Science. 1994 Sep 2;265(5177):1346-7
pubmed: 7802784
J Syst Integr Neurosci. 2020 Aug;6(2):
pubmed: 33614164
JAMA. 1991 Oct 2;266(13):1801-7
pubmed: 1832467
Curr Psychopharmacol. 2020;9(1):7-21
pubmed: 32432025
J Neurochem. 2001 Sep;78(5):1094-103
pubmed: 11553683
Sci Am. 1992 Apr;266(4):29, 32
pubmed: 1533054
Biol Psychiatry. 1993 Jan 15;33(2):108-14
pubmed: 8094979
BMC Neurosci. 2020 Mar 26;21(1):12
pubmed: 32216748
Mol Neurobiol. 2021 Jul;58(7):3335-3346
pubmed: 33683627
Biol Psychiatry. 1996 Oct 15;40(8):776-84
pubmed: 8894071
Science. 1994 Jun 17;264(5166):1696-7
pubmed: 8209249
Med Hypotheses. 1994 Apr;42(4):257-60
pubmed: 8072432
Synapse. 2008 Jul;62(7):481-6
pubmed: 18418874
J Pers Med. 2022 Apr 26;12(5):
pubmed: 35629112
Curr Psychopharmacol. 2021 Feb 15;10:
pubmed: 34707969
JAMA. 1990 Apr 18;263(15):2055-60
pubmed: 1969501
JAMA. 1993 Oct 6;270(13):1547-8
pubmed: 8371464
Alcohol Clin Exp Res. 1998 Jun;22(4):845-8
pubmed: 9660310
J Psychopharmacol. 2022 Mar;36(3):409-422
pubmed: 35102768
Funct Neurol. 1995 Jan-Feb;10(1):37-44
pubmed: 7649500
Pharmacogenetics. 1997 Dec;7(6):479-84
pubmed: 9429233
Nat Ment Health. 2023 Mar;1(3):210-223
pubmed: 37250466
Annu Rev Psychol. 2020 Jan 4;71:79-106
pubmed: 31905114
J Pers Med. 2022 Feb 21;12(2):
pubmed: 35207809